Publication:
Highly potent cholinesterase inhibition of geranylated xanthones from Garcinia fusca and molecular docking studies

dc.contributor.authorSaenkham A.
dc.contributor.authorJaratrungtawee A.
dc.contributor.authorSiriwattanasathien Y.
dc.contributor.authorBoonsri P.
dc.contributor.authorChainok K.
dc.contributor.authorSuksamrarn A.
dc.contributor.authorNamsa-Aid M.
dc.contributor.authorPattanaprateeb P.
dc.contributor.authorSuksamrarn S.
dc.date.accessioned2021-04-05T03:01:15Z
dc.date.available2021-04-05T03:01:15Z
dc.date.issued2020
dc.date.issuedBE2563
dc.description.abstractThree new oxygenated xanthones, fuscaxanthones L-N (1–3), and 14 known xanthones 4–17, together with the other known metabolites 18–20 were isolated from the stem barks of Garcinia fusca Pierre. Their chemical structures were determined based on NMR and MS spectroscopic data analysis, as well as single X-ray crystallography. The geranylated compounds, cowanin (13), cowagarcinone E (15), norcowanin (16) and cowanol (17) exhibited potent inhibitions against acetylcholinesterase (AChE) (IC50 0.33–1.09 μM) and butyrylcholinesterase (BChE) (IC50 0.048–1.84 μM), which were more active than the reference drug, galanthamine. Compound 15 was highly potent BChE inhibitor (IC50 0.048 μM) and was 76-fold more potent than the drug. Structure-activity relationship studies indicated that the C-2 prenyl and C-8 geranyl substituents in the tetraoxygenated scaffold are important for high activity. Molecular docking studies revealed that the leads 13 and 15–17 showed similar binding orientations on both enzymes and very well-fitted at the double binding active sites of PAS and CAS with strong hydrophobic interactions from both isoprenyl side chains. © 2020 Elsevier B.V.
dc.format.mimetypeapplication/pdf
dc.identifier.citationFitoterapia. Vol 146, (2020)
dc.identifier.doi10.1016/j.fitote.2020.104637
dc.identifier.issn0367326X
dc.identifier.other2-s2.0-85086117321
dc.identifier.urihttps://hdl.handle.net/20.500.14740/4386
dc.rights.holderScopus
dc.subject.otherAcetylcholinesterase
dc.subject.otherCholinesterase
dc.subject.otherCowagarcinone e
dc.subject.otherCowanin
dc.subject.otherCowanol
dc.subject.otherFuscaxanthone l
dc.subject.otherFuscaxanthone m
dc.subject.otherFuscaxanthone n
dc.subject.otherGalantamine
dc.subject.otherNorcowanin
dc.subject.otherUnclassified drug
dc.subject.otherXanthone derivative
dc.subject.otherArticle
dc.subject.otherBark
dc.subject.otherCholinesterase inhibition
dc.subject.otherDrug binding site
dc.subject.otherDrug isolation
dc.subject.otherDrug potency
dc.subject.otherDrug structure
dc.subject.otherGarcinia
dc.subject.otherGarcinia fusca
dc.subject.otherHydrophobicity
dc.subject.otherMass spectrometry
dc.subject.otherMolecular docking
dc.subject.otherNonhuman
dc.subject.otherNuclear magnetic resonance spectroscopy
dc.subject.otherPlant stem
dc.subject.otherPriority journal
dc.subject.otherStructure activity relation
dc.subject.otherX ray crystallography
dc.titleHighly potent cholinesterase inhibition of geranylated xanthones from Garcinia fusca and molecular docking studies
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85086117321&doi=10.1016%2fj.fitote.2020.104637&partnerID=40&md5=b0718662332cc7ac3056a6b267319b77

Files